These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 8840973

  • 21. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 22. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP, Li BJ, Zhang C.
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [Abstract] [Full Text] [Related]

  • 23. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N, Kuriyama H, Julin CM, Lamborn KR, Israel MA.
    Cancer Res; 2001 Mar 01; 61(5):1805-9. PubMed ID: 11280727
    [Abstract] [Full Text] [Related]

  • 24. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 01; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 25. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT.
    Clin Cancer Res; 1995 Dec 01; 1(12):1571-80. PubMed ID: 9815958
    [Abstract] [Full Text] [Related]

  • 26. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR, Bartlett DL.
    Cancer Gene Ther; 2000 Jan 01; 7(1):66-73. PubMed ID: 10678358
    [Abstract] [Full Text] [Related]

  • 27. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 01; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 28. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec 01; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 29. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.
    Cancer Res; 2001 Aug 15; 61(16):6012-9. PubMed ID: 11507044
    [Abstract] [Full Text] [Related]

  • 30. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC, van Someren GD, Vincent AJ, van Bekkum DW, Valerio D, Bout A, Noteboom JL.
    Gene Ther; 1997 Apr 15; 4(4):280-7. PubMed ID: 9176512
    [Abstract] [Full Text] [Related]

  • 31. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A, Määttä AM, Pasanen T, Tulimäki K, Wahlfors J.
    Int J Mol Med; 2004 May 15; 13(5):705-10. PubMed ID: 15067374
    [Abstract] [Full Text] [Related]

  • 32. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2003 Apr 15; 10(4):260-9. PubMed ID: 12679798
    [Abstract] [Full Text] [Related]

  • 33. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K, Brust D, Farnsworth J, Amir C, Taher MM, Hershey C, Feden J.
    Cancer Gene Ther; 2000 Jun 15; 7(6):879-84. PubMed ID: 10880018
    [Abstract] [Full Text] [Related]

  • 34. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
    Sutton MA, Berkman SA, Chen SH, Block A, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Woo SL, Lerner SP.
    Urology; 1997 Feb 15; 49(2):173-80. PubMed ID: 9037277
    [Abstract] [Full Text] [Related]

  • 35. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
    Nagy HJ, Panis Y, Fabre M, Klatzmann D, Houssin D, Soubrane O.
    Anticancer Res; 2000 Feb 15; 20(6B):4633-8. PubMed ID: 11205314
    [Abstract] [Full Text] [Related]

  • 36. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ, Sanford MA, Atkinson G, Chen SH.
    Cancer Res; 1998 Aug 01; 58(15):3221-5. PubMed ID: 9699645
    [Abstract] [Full Text] [Related]

  • 37. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K, Löser P, Arnold W, Bartels T, Strauss M.
    Gene Ther; 1998 Oct 01; 5(10):1363-71. PubMed ID: 9930342
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M, Ryuke Y, Yoshida J.
    Cancer Gene Ther; 2002 Oct 01; 9(10):825-9. PubMed ID: 12224023
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.